Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis

被引：0
作者：
Roisin Adams
Cathal Walsh
Douglas Veale
Barry Bresnihan
Oliver FitzGerald
Michael Barry
机构：
[1] St. James’ Hospital,National Centre for Pharmacoeconomics
[2] Trinity College Dublin,Department of Statistics
[3] Dublin Academic Healthcare,St. Vincent’s University Hospital
来源：
PharmacoEconomics | 2010年 / 28卷
关键词：
Rheumatoid Arthritis; Inflammatory Arthritis; Biological Therapy; Utility Score; Disease Activity Score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The growth of economic analyses and in particular cost-utility analyses (CUA), which use the QALY as a measure of outcome, has heightened the interest in the methodologies used to calculate the QALY. The EQ-5D has produced quite different utility values from that of the SF-6D. This article seeks to understand these differences using a cohort of patients with inflammatory arthritis.
引用
收藏
页码：477 / 487
页数：10
相关论文
共 101 条
[1]  
Yelin E(1995)The economic cost and social and psychological impact of musculoskeletal conditions Arthritis Rheum 38 1351-62
[2]  
Callahan LF(2008)Economic burden of psoriatic arthritis Pharmacoeconomics 26 121-9
[3]  
Ackermann C(1996)Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria Arthritis Rheum 39 34-40
[4]  
Kavanaugh A(1994)Validity of Euro-QoL: a generic health status instrument in patients with rheumatoid arthritis Rheumatology (Oxford) 33 655-62
[5]  
van Gestel AM(1992)The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection Med Care 30 473-83
[6]  
van ’t Prevoo M H(1980)Measurement of patient outcomes in arthritis Arthritis Rheum 23 137-45
[7]  
Hurst N(2005)Measuring health-related utility: why the disparity between EQ-5D and SF-6D Eur J Health Econ 6 253-60
[8]  
Jobanputra P(2006)Comparison of EQ-5D and SF-6D utilities in mental health patients Health Econ 15 1229-36
[9]  
Hunter M(2004)EQ-5D versus SF- 6D in an older, chronically ill patient group Appl Health Econ Health Policy 3 91-102
[10]  
Ware JE(2005)Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis Rheumatology (Oxford) 44 1169-75
12345678910